PharmiWeb.com - Global Pharma News & Resources

Medical comms - Press Releases

Date Title Company
20-May-2020 Why research on ticks could offer potential COVID-19 breakthrough ILC Therapeutics
20-May-2020 European Commission Approves Subcutaneous Formulation of Entyvio® (Vedolizumab) for use as Maintenance Therapy in Adults with Moderately to Severely Active Ulcerative Colitis or Crohn’s Disease Takeda Pharmaceutical Company Limited
20-May-2020 ASLAN PHARMACEUTICALS REPORTS FIRST QUARTER 2020 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE ASLAN Pharmaceuticals
20-May-2020 4D Pharma: successful completion of immuno-oncology study safety phase 4D pharma plc
20-May-2020 New COVID-19 Antibody Testing Partnership Quotient Limited and hVIVO Announce Partnership to Support Wide-Spread COVID-19 Antibody Testing in the UK Open Orphan plc
20-May-2020 HUMMINGBIRD BIOSCIENCE CLOSES US$25 MILLION INVESTMENT WITH SERIES B EXTENSION Hummingbird Bioscience
20-May-2020 Senzer to create targeted anti-viral treatments for COVID-19 Launch of Critical Care Division Senzer Pharmaceuticals
20-May-2020 GILEAD AND KITE CONTINUE TO ADVANCE NEXT GENERATION CANCER THERAPIES AT 2020 AMERICAN SOCIETY OF CLINICAL ONCOLOGY ANNUAL MEETING Gilead Sciences, Inc.
20-May-2020 Breakthrough Innovation in Cancer Care From Merck Pipeline to Be Presented at ASCO 2020 Merck
20-May-2020 Nivolumab plus ipilimumab with chemotherapy shows improved overall survival vs. chemotherapy alone in first-line metastatic nonsmall cell lung cancer in a phase 3 trial Bristol Myers Squibb
20-May-2020 Orgenesis announces cell-based vaccine platform targeting COVID-19 and other existing and emerging viral diseases Orgenesis
20-May-2020 IDT broadens capacity and customer support of COVID-19 products with new manufacturing facility Integrated DNA Technologies, Inc. (IDT)
20-May-2020 Sanofi to showcase oncology portfolio and innovative pipeline at ASCO20 Virtual Scientific Program Sanofi
20-May-2020 Danish Team of Researchers to Test Treatment of Critically Ill Patients Suffering from COVID-19 BioPorto
20-May-2020 Jazz Pharmaceuticals to Showcase New Data From its Growing Oncology Portfolio at Virtual ASCO and EHA 2020 Meetings Jazz Pharmaceuticals plc
20-May-2020 2020 ASCO Annual Meeting Publishes Three New Abstracts Based on Real-World Data Generated from Belong.Life’s Patient Engagement Network Belong.Life
20-May-2020 Exvastat receives prestigious Innovative Medicines Initiative grant to fund clinical study of imatinib in the treatment of COVID-19-associated ARDS Exvastat Ltd
20-May-2020 Transgene and BioInvent present preclinical data demonstrating BT-001’s powerful activity against solid tumors Transgene
20-May-2020 Roche becomes founding partner of BaseLaunch Phase II BaseLaunch
20-May-2020 MediPharm Labs Australia Signs First European White-Label Cannabis Supply Agreement With UK-Based Cannaray’s Therismos MediPharm Labs